Gloria V Mercado, MD | |
387 Quarry St, Suite 100, Fall River, MA 02723-1025 | |
(508) 679-8111 | |
(508) 674-5028 |
Full Name | Gloria V Mercado |
---|---|
Gender | Female |
Speciality | General Practice |
Experience | 46 Years |
Location | 387 Quarry St, Fall River, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1578628715 | NPI | - | NPPES |
3003604 | Medicaid | MA | |
412269 | Other | RI | BC BS OF RI (BLUECHIP) |
44289 | Other | MA | CHILDREN'S MEDICAL SP |
0039507 | Other | MA | NEIGHBORHOOD HEALTH PLAN |
0103124 | Other | MA | UNITEDHEALTHCARE |
210126 | Other | RI | BC BS OF RI |
961245-01 | Other | MA | NETWORK HEALTH |
J05037 | Other | MA | BC BS OF MA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208D00000X | General Practice | 51934 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Southcoast Visiting Nurse Association Inc | Fairhaven, MA | Home health agency |
Accentcare Home Health Of Massachusetts | Westwood, MA | Home health agency |
Southcoast Hospitals Group | Fall river, MA | Hospital |
Saint Anne's Hospital | Fall river, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Healthfirst Family Care Center Inc | 0042120297 | 21 |
News Archive
VirtualScopics, Inc., a leading provider of image-based solutions to the pharmaceutical, biotechnology and medical device industries, announced today that on January 4, 2012 it received a notice from the NASDAQ Stock Market indicating that the Company's minimum bid price has fallen below $1.00 for 30 consecutive business days.
The results from a new study published in The Lancet demonstrate that high- quality measles immunization campaigns and improvements in routine immunization services have reduced measles cases by 91% in 19 African nations from 2000-2003, preventing an estimated 90,000 child deaths in 2003 alone.
A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of phase III IMpower150 trial presented at the ESMO Immuno Oncology Congress 2017.
Aegerion Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at $9.50 per share, before underwriting discounts and commissions.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Gloria V Mercado, MD 387 Quarry St, Suite 100, Fall River, MA 02723-1025 Ph: (508) 679-8111 | Gloria V Mercado, MD 387 Quarry St, Suite 100, Fall River, MA 02723-1025 Ph: (508) 679-8111 |
News Archive
VirtualScopics, Inc., a leading provider of image-based solutions to the pharmaceutical, biotechnology and medical device industries, announced today that on January 4, 2012 it received a notice from the NASDAQ Stock Market indicating that the Company's minimum bid price has fallen below $1.00 for 30 consecutive business days.
The results from a new study published in The Lancet demonstrate that high- quality measles immunization campaigns and improvements in routine immunization services have reduced measles cases by 91% in 19 African nations from 2000-2003, preventing an estimated 90,000 child deaths in 2003 alone.
A new combination therapy for the first line treatment of advanced non-squamous non-small-cell lung cancer (NSCLC) improves progression-free survival (PFS), according to results of phase III IMpower150 trial presented at the ESMO Immuno Oncology Congress 2017.
Aegerion Pharmaceuticals, Inc. announced today the pricing of its initial public offering of 5,000,000 shares of its common stock at $9.50 per share, before underwriting discounts and commissions.
› Verified 5 days ago